A patient’s journey from Arizona to the U-M Rogel Cancer Center to participate in clinical research led to the successful removal of her cancerous tumor. The trial involved adding an oral agent known as AZD 1775 to chemotherapy and radiation. In laboratory studies, it did a better job killing pancreatic cancer cells.
Between 50 to 60 percent of patients who receive donated bone marrow or stem cells develop a major complication called graft-versus-host disease, with a mortality rate of 75 to 100 percent among those with the most severe cases of the disease.
That’s why Sung Won Choi, MD, MS has devoted the past decade of her career to research intended not only to better treat GVHD but also to prevent it from occurring in the first place.
“It’s the most talked about pain kids experience, even more so than post-op surgical pain.” Julie Piazza, a certified child life specialist, is referring to needlestick pain from pediatric blood draws. As project manager for patient and family-centered care at C.S. Mott Children’s Hospital, she has observed anxiety at both ends of the needle.